Featured Posts
ATR Applauds Progress on Hospital Billing Transparency
Washington has spent years debating healthcare costs without confronting the biggest one: hospitals. Thankfully, both lawmakers and private industry have taken the initiative to…
Commentary
Sending Big Government After Medication Retailers Won’t Help What’s Ailing American Healthcare
America’s healthcare affordability crisis is much larger than pharmacy benefit managers (PBMs). CMS projects national healthcare spending of about $5.7 trillion in 2025, or…
Commentary
ATR Supports the Alzheimer’s Screening and Prevention Act
Today, Americans for Tax Reform sent a letter to members of Congress urging the progression and passage of the Alzheimer’s Screening and Prevention…
Commentary
Filtered Posts
ATR Supports IP Rights, Opposes the Medication Affordability and Patent Integrity Act
Commentary
30 Free Market Groups, Advocates Oppose Efforts to Quash DTC Pharmaceutical Ads
Commentary
Medicare, Medicaid, and the Hospital Cost Crisis
Commentary
FRESH and Affordable Foods Act Would Rightly Establish a Uniform, Science-Based Standard for Food Safety
Commentary
Section 232 Pharmaceutical Tariffs Hurt Patients and Threaten America’s Global Competitiveness
Commentary
The House Energy and Commerce Committee Is Sounding the Alarm on Medicaid Fraud
Commentary
Trump Administration Begins Crackdown on Medicaid Provider Tax Scheme
Commentary
A Prescription for Decline: Biden’s Drug Price Controls Are Hurting the Patients It Promised to Serve
Commentary
America Can’t Afford to Slow Medical Innovation
Commentary
Ingredient Regulations Threaten a 12% Grocery Price Increase
Commentary